Ignite Creation Date:
2024-05-06 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05128734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-31
First Post:
2021-10-27
Brief Title:
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer TNBC
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-27
First Submit QC Date:
November 17 2021
Study First Post Date:
2021-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-29
Last Update Post Date:
2024-01-31
Last Update Post Date Type:
ACTUAL